One of our fantastic clinical science consultants, Marjorie Zettler, PhD, MPH, penned an article outlining updated FDA guidance for dose optimization in drug development. It highlights how companies incorporating this kind of study design can provide a real benefit to their patient populations, particularly in the Oncology sector where tolerability and risk are massive drivers. Very much worth a read, and if your company is doing this, it would be great to hear about how it has shaped approval, uptake, and outcomes! https://lnkd.in/eDj2fc5N
关于我们
The Conjugate Group provides flexible drug development services and resources. The scope of our services ranges from strategic consulting and functional staff augmentation to comprehensive, deliverable-based solutions starting from IND Enabling through Commercial launch. Our people are industry veterans with numerous accolades and accomplished careers in their respective areas of expertise. These functions include: Program and Portfolio Management, Medical Writing, CMC, Regulatory Affairs and Submissions, Quality Assurance (GxP), Medical Affairs, Clinical Operations, Biostatistics and Programming, and more.
- 网站
-
https://www.conjugategroup.com/
Conjugate Group的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 51-200 人
- 总部
- Waltham，Massachusetts
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Consulting、Pharmaceutical Development、Study Design、Program Management、CMC、Regulatory Affairs、Quality Assurance、Medical Affairs、Clinical Operations、Biostatistics、Partnerships和Alliance Management
地点
-
主要
获取路线
330 Bear Hill Rd.
304
US，Massachusetts，Waltham，02451
Conjugate Group员工
-
Patrick Gill
Building innovative and creative solutions to bridge the gap between resources, timelines and budget, for drug development and device companies and…
-
Gina Brower, PMP?
Project Manager | Lab Operations Manager | Cross Functional Collaboration | Risk | Budget Management | Biopharma | Diagnostics
-
Jesse Nandhavan
Representing the best clinical development professionals in the biotech and pharmaceutical industries
-
Sean Malkus
Drug Development Strategy and Execution
动态
-
Interesting story. We are seeing an increase in our clients asking for more face time. Not necessarily with our consultants but with our client decision makers. Though, at times our clients are asking for monthly face-to-face meetings with our consultants, dependent upon project/skill-set. We will see...
此处无法显示此内容
在领英 APP 中访问此内容等
-
I have been working with growing/emerging biopharma groups for over 25 years in the Boston/Cambridge area. At Conjugate Group, we speak with hundreds of industry leaders and professionals each week and see a larger picture, even trends/counter trends. With the reality of 2023 staring Conjugate in the face a year ago, I decided to use it as a growth year, building capability and staff to meet the returning demand of 2024/2025. As we get into the 3rd Quarter of 2024 its important to know what we are experiencing. We've realized strong growth using 1st Quarter of 2023 as a baseline. There are more requests for our clinical development and operations people, for example. This is good for that subset of professionals that were the most affected by the downturn in late 2022/2023. And remember: stability is not getting a job at any one firm be it Pfizer or Novartis, etc. Rather, I have always thought of stability being the sum of your skills, attitude and network. Network, perhaps, being the most key thing in the equation. If these 3 things are alive and growing, you will weather the storms of biotech every time. We are excited for 2025!
-
Rare diseases have been a cornerstone of our work since our inception. Working as a partner to the biotech community, many of our clients are promoting cutting edge and novel therapies for these conditions, which without the efforts of insightful investors, gifted scientists, and indefatigable clinical researchers would not be possible. Today, on Rare Disease Day, we stand together to raise awareness and advocate for those affected by these conditions. At Conjugate Group, we're not just observers; we're actively engaged in the fight, and we're dedicated to contributing to clinical progress and aiding discovery efforts to find cures. Supporting Rare Disease Research: From trial design, to approval pathways, to study management, we facilitate connections between passionate experts and organizations driving breakthroughs in rare disease research. we're here to support recruitment needs on the frontline against rare diseases. Join Us: This Rare Disease Day, let's drive change together. Whether you're a rare disease expert in a function we represent, or a company seeking top-tier talent, let's connect. Together, we can overcome rare diseases and pave the way for a healthier future #MedicalRareDiseaseDay #RareDiseaseAwareness #ConjugateGroup #DrugDevelopment #ClinicalProgress #LifeSciences #JoinTheFight
-
-
?? Exciting News! ?? We are thrilled to share that Conjugate Group, a leader in Flexible Drug Development? services, has expanded its offerings to include Executive Search. This strategic move reinforces our commitment to client success in the Biopharmaceutical industry. With a strong track record in Consulting and Contract Services, we're now uniquely positioned to provide tailored Executive Search solutions. Our Group will help organizations secure top-tier executive talent, empowering them to build visionary leadership teams in the dynamic landscape of drug development. Strong leadership is pivotal to success, and our Executive Search services aim to facilitate just that. Read the full press release here: https://lnkd.in/e2f-s7hZ #ConjugateGroup #ExecutiveSearch #Biopharmaceutical #DrugDevelopment #LeadershipSolutions #InnovationInHealthcare
Conjugate Group Expands Services with Strategic Addition of Executive Search - Conjugate Group
https://www.conjugategroup.com
-
?? Exciting News! ?? We are thrilled to share that Conjugate Group, a leader in Flexible Drug Development? services, has expanded its offerings to include Executive Search. This strategic move reinforces our commitment to client success in the Biopharmaceutical industry. With a strong track record in Consulting and Contract Services, we're now uniquely positioned to provide tailored Executive Search solutions. Our Group will help organizations secure top-tier executive talent, empowering them to build visionary leadership teams in the dynamic landscape of drug development. Strong leadership is pivotal to success, and our Executive Search services aim to facilitate just that. Read the full press release here: https://lnkd.in/e2f-s7hZ #ConjugateGroup #ExecutiveSearch #Biopharmaceutical #DrugDevelopment #LeadershipSolutions #InnovationInHealthcare
Conjugate Group Expands Services with Strategic Addition of Executive Search - Conjugate Group
https://www.conjugategroup.com
-
Ihab Alter, MBA is #hiring. Know anyone who might be interested?